Myosin’s Molecular Toggle: How Dimerization of the Globular Tail Domain Controls the Motor Function of Myo5a
Myo5a exists in either an inhibited, triangulated rest or an extended, motile activation, each conformation dictated by the interplay between the GTD and its surroundings.
Invisible Couriers: How Lab-on-Chip Technologies Are Rewriting the Future of Disease Diagnosis
The shift from benchtop Western blots to on-chip, real-time protein detection represents more than just technical progress—it is a shift in epistemology.
Designing Better Sugar Stoppers: Engineering Selective α-Glucosidase Inhibitors via Fragment-Based Dynamic Chemistry
One of the most pressing challenges in anti-diabetic therapy is reducing the unpleasant and often debilitating gastrointestinal side effects that accompany α-amylase inhibition.
The Heart’s Hidden Architects: Reprogramming Cardiac Regeneration Through Intracellular Stem Cell Engineering
Cardiac regeneration, once dismissed as a biological impossibility, has now become a question not of “if,” but of “how.”
Into the Genomic Unknown: The Hunt for Drug Targets in the Human Proteome’s Blind Spots
The proteomic darkness is not empty. It is rich with uncharacterized function, latent therapeutic potential, and untapped biological narratives.
REM-422, RNA Processing, and the Next Wave of Translational Science with Benoît Moreau, Remix Therapeutics
Benoît Moreau, Ph.D., discusses RNA-targeted drug discovery at Remix Therapeutics and the advancement of small molecules like REM-422 to tackle undruggable targets.
Daily News
Setting the Benchmark: Shaping Analytical Standards to Accelerate Global Convergence in Biologics Quality Systems with Stephan Krause, Bristol Myers Squibb
Research & Development
Myosin’s Molecular Toggle: How Dimerization of the Globular Tail Domain Controls the Motor Function of Myo5a
Myo5a exists in either an inhibited, triangulated rest or an extended, motile activation, each conformation dictated by the interplay between the GTD and its surroundings.
Designing Better Sugar Stoppers: Engineering Selective α-Glucosidase Inhibitors via Fragment-Based Dynamic Chemistry
One of the most pressing challenges in anti-diabetic therapy is reducing the unpleasant and often debilitating gastrointestinal side effects that accompany α-amylase inhibition.
Clinical Trials & Regulation
Manufacturing & Bioprocesses
Magnetic Nanoengineering: Overcoming Biological Variability and Enhancing Therapeutic Precision
The future of nanomedicine lies in harmonizing precision, accessibility, and ecological responsibility, ushering in an era where therapies are tailored to individual biological landscapes.
Epidemiology & Public Health
Two-Dimensional Neural Geometry: A Revolution in Understanding Human Working Memory
Working memory, a cornerstone of human cognition, has long been mischaracterized as a passive storage system.
Harnessing IgA: A Breakthrough in HIV Vaccine Innovation
A vaccine eliciting strong IgA responses could revolutionize HIV prevention by protecting the virus’s primary entry points.
Prostate Cancer Precision-Targeting: The Promise and Challenges of Vaccine Therapies
The future of prostate cancer vaccines lies in combination therapies that harness the strengths of multiple modalities.
Appreciating the Orphan: Structural Insights Into GPR6 as a Target for Parkinson’s Disease
The discovery of GPR6’s structural and functional properties marks a paradigm shift in Parkinson’s research.
Subscribe
to get our
LATEST NEWS
Upcoming
East Coast - Boston
Chemistry, Manufacturing & Controls Strategy Meeting East Coast USA 2025
7th of May, 2025
Learn moreMedicinal Chemistry Strategy Meeting East Coast USA 2025
8th of May, 2025
Learn moreMedicinal Chemistry & Drug Discovery Biology Strategy Meeting East Coast USA 2025
14th of May, 2025
Learn moreClinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast USA 2025
15th of May, 2025
Learn more